Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4
Welcome,         Profile    Billing    Logout  
 8 Trials 
13 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Baldi, Giacomo G
METROPHOLYS, NCT04656262 / 2018-001075-20: Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients

Terminated
3
79
Europe
Cyclophosphamide, Endoxan, Doxorubicin
Istituto Oncologico Veneto IRCCS, Ministry of Health, Italy
Soft Tissue Sarcoma Adult
05/24
05/24
JADE, NCT06256588: A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Recruiting
3
864
Europe, Canada, Japan, US, RoW
Dostarlimab, Placebo
GlaxoSmithKline
Neoplasms, Head and Neck
05/28
07/29
MANEUVER, NCT05804045: Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor

Active, not recruiting
3
90
Europe, Canada, US, RoW
Pimicotinib(ABSK021), Placebo
Abbisko Therapeutics Co, Ltd
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath
05/26
06/28
STRADA, NCT03023124 / 2016-004051-78: Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor

Active, not recruiting
2
23
Europe
Trabectedin, Adriamycin, Dacarbazine
Italian Sarcoma Group
Solitary Fibrous Tumors
12/24
12/24
ChonDRAgon, NCT04950075: Study of INBRX-109 in Conventional Chondrosarcoma

Recruiting
2
201
Europe, US, RoW
INBRX-109, Placebo
Inhibrx Biosciences, Inc
Conventional Chondrosarcoma
12/24
07/25
ISG-ARTICLE, NCT04383119: Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma

Recruiting
2
100
Europe
Trabectedin, Trabectedin arm, Gemcitabine, Gemcitabine arm, No Intervention: Observational Cohort
Italian Sarcoma Group, PharmaMar
Leiomyosarcoma of Ovary, Soft Tissue Sarcoma
06/24
09/24
ISG-MCS, NCT04305548: Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Recruiting
2
16
Europe
Trabectedin
Italian Sarcoma Group, PharmaMar
Mesenchymal Chondrosarcoma
09/24
12/24
TOMAS2, NCT03838744 / 2018-004497-10: Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

Active, not recruiting
2
126
Europe
Standard arm: Trabectedin in monotherapy, Trabectedin arm, Experimental arm: Trabectedin + Olaparib, Trabectedin+ Olaparib arm
Italian Sarcoma Group, PharmaMar, AstraZeneca
Advanced Soft Tissue Sarcoma
02/25
02/25
Breast-Sarc, NCT04749446: Study on Clinical Features and Outcomes of Breast Sarcoma

Recruiting
N/A
300
Europe
Treatment of Breast Sarcoma according clinical practice (includes drugs, surgery or any other received treatments)
Italian Sarcoma Group
Breast Sarcoma
12/23
12/23
EHE, NCT06408441: The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

Recruiting
N/A
100
Europe
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, EHE Rare Cancer Charity UK
Epithelioid Hemangioendothelioma, Sarcoma,Soft Tissue
12/33
12/33
NCT02829437: Observational Study on Endometrial Stromal Tumors

Recruiting
N/A
100
Europe
Treatment for EST
Italian Sarcoma Group
Endometrial Stromal Tumors
12/24
12/24
EPISObs, NCT03099681: An Observational Study on Epithelioid Sarcoma

Recruiting
N/A
100
Europe
Treatment for Epitheloid Sarcoma
Italian Sarcoma Group
Epithelioid Sarcoma
12/24
12/24
EURACAN, NCT05483374: The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

Recruiting
N/A
13600
Europe, RoW
observation
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Associazione Italiana Oncologia Cervico Cefalica, Ministry of Health, Italy, European Union, Alleanza Contro il Cancro
Head and Neck Cancer, Nasopharynx Cancer, Nasal Cavity and Paranasal Sinus Cancer, Salivary Gland Cancer, Middle Ear Carcinoma
12/30
12/30

Download Options